Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
4Basebio PLC banner
4

4Basebio PLC
LSE:4BB

Watchlist Manager
4Basebio PLC
LSE:4BB
Watchlist
Price: 570 GBX -0.87% Market Closed
Market Cap: £88.6m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

4BB Price Targets Summary
4Basebio PLC

Wall Street analysts forecast 4BB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4BB is 1 734 GBX with a low forecast of 1 616 GBX and a high forecast of 1 890 GBX.

4BB Lowest Forecast
Wall Street Target
1 616 GBX
184% Upside
4BB Average Forecast
Wall Street Target
1 734 GBX
204% Upside
4BB Highest Forecast
Wall Street Target
1 890 GBX
232% Upside
Lowest
Price Target
1 616 GBX
184% Upside
Average
Price Target
1 734 GBX
204% Upside
Highest
Price Target
1 890 GBX
232% Upside
4Basebio PLC Competitors:
Price Targets
ITRN
Ituran Location and Control Ltd
6% Upside
8841
TOC Co Ltd
25% Upside
PTCT
PTC Therapeutics Inc
28% Upside
GOSS
Gossamer Bio Inc
310% Upside
ITRN
Ituran Location and Control Ltd
6% Upside
8841
TOC Co Ltd
25% Upside
PTCT
PTC Therapeutics Inc
28% Upside
GOSS
Gossamer Bio Inc
310% Upside

Revenue
Forecast

19% / Year
Past Growth
131% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
19% / Year
Past Growth
131% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 4 years the compound annual growth rate for 4Basebio PLC's revenue is 19%. The projected CAGR for the next 4 years is 131%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss

What are analyst estimates?

See Also

Summary
4BB intrinsic value, competitors valuation, and company profile.
DCF Valuation
4BB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
4BB stock valuation using valuation multiples.
Wall Street Estimates
4BB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
4BB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 4BB's stock price target?
Price Target
1 734 GBX

According to Wall Street analysts, the average 1-year price target for 4BB is 1 734 GBX with a low forecast of 1 616 GBX and a high forecast of 1 890 GBX.

What is 4Basebio PLC's Revenue forecast?
Projected CAGR
131%

For the last 4 years the compound annual growth rate for 4Basebio PLC's revenue is 19%. The projected CAGR for the next 4 years is 131%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.